Anand Mahindra had tweeted about Amitabh Bachchan’s “inbuilt vaccine” – Big V.
Last month, when actor Amitabh Bachchan introduced that he had examined constructive for COVID-19, Anand Mahindra had wished him a speedy restoration, writing: “There’s a vaccine you possess – it’s code named the Big V – and it’s inbuilt & organic. Grows inside all those like you who are natural fighters.” Now that Mr Bachchan has recovered and is again house from the hospital, Mr Mahindra needs the CEO of Serum Institute to fabricate this “Big V’ vaccine.
In a tweet shared on Sunday, Mr Mahindra first welcomed Amitabh Bachchan back after he announced he had been discharged from the hospital where he had been undergoing treatment. “As I had mentioned, you possessed an inbuilt vaccine codenamed the Big V,” wrote Anand Mahindra, 65.
Then, in a lighthearted aside, he added: “Now we’d like @adarpoonawalla to discover a option to extract it from you, manufacture it & give us all a dose…”
Welcome back @SrBachchan As I had said, you possessed an inbuilt vaccine codenamed the Big V. Now we need @adarpoonawalla to find a way to extract it from you, manufacture it & give us all a dose…???? https://t.co/8aP9o2IzA9
— anand mahindra (@anandmahindra) August 2, 2020
Mr Poonawalla is the CEO and owner of the Serum Institute of India, which is the world’s largest vaccine manufacturer and will mass-produce doses of a potential vaccine against the new coronavirus.
He responded to the Chairman of Mahindra Group and assured him that his scientists were already “engaged on it”.
“Haha! good one @anandmahindra, my scientists are engaged on it,” quipped Mr Poonawalla. He also welcomed Mr Bachchan back.
Haha! good one @anandmahindra, my scientists are working on it! and great to have you back, @SrBachchan. https://t.co/1IO9BbG5ts
— Adar Poonawalla (@adarpoonawalla) August 2, 2020
The exchange between Mr Mahindra and Mr Poonawalla has delighted Twitter, garnering thousands of ‘likes’ and comments.
The coronavirus vaccine developed at the Oxford University will be in India by November. “We are assured on happening to the Phase three trials in India in August and we forecast that it’ll take most likely two to two-and-half months to finish… By November, we hope to launch the vaccine if the trials are constructive and if the Drug Controller of India blesses it and says it’s secure and efficient,” Mr Poonawalla told NDTV.
Click for extra trending news
